-
-
-
-
-
-
-
Amneal to Report Second Quarter 2026 Results on July 30, 2026
-
-
-
-
-
-
-
Amneal receives FDA approval for romidepsin injection solution
-
-
-
-
-
-
-
Amneal Launches First Two Respiratory Metered-Dose Inhalation Products in the U.S.
-
-
-
-
-
-
-
Amneal to Report Fourth Quarter and Full Year 2025 Results on February 27, 2026
-
-
-
-
-
-
-
Amneal gets FDA approval for generic albuterol inhaler
-
-
-
-
-
-
-
Amneal Reports Third Quarter 2025 Financial Results
-
-
-
-
-
-
-
Amneal gets FDA approval for generic glaucoma treatment
-
1,217,542 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

